Skip to main content
Top
Published in: Acta Diabetologica 2/2020

01-02-2020 | Diabetic Retinopathy | Original Article

Diabetic retinopathy screening using a virtual reading center

Authors: Ronald B. Melles, Carol Conell, Scott W. Siegner, Dariusz Tarasewicz

Published in: Acta Diabetologica | Issue 2/2020

Login to get access

Abstract

Aims

To summarize the effects of centralization of diabetic fundus photograph interpretation into a virtual reading center.

Methods

In 2016 Kaiser Permanente Northern California, a large, membership-based health plan with an ethnically and racially diverse population, centralized diabetic retinopathy screening into a virtual reading center. Retina screens were based on single field, 45-degree fundus photographs. We compared the accuracy of photography interpretation the year before centralization to the year after using masked reads performed by retina specialists of 1000 randomly selected screens from each time period.

Results

In all, 1902 patient screens with adequate quality images were included in the primary analysis. Images from pre-centralization screens were largely read by ophthalmologists (76.2%), while screens post-centralization were mainly read by optometrists (84.6%). Despite being interpreted by readers with lower levels of professional training, the sensitivity of screening increased from 43.9% (95% CI 38.0–49.8%) to 66.0% (95% CI 60.5–71.4%).

Conclusion

A move to a centralized virtual reading center was associated with improved accuracy of diabetic retinopathy screening.
Literature
1.
go back to reference Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis 2:1–25CrossRef Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis 2:1–25CrossRef
2.
go back to reference Ogurtsova K, da Rocha Fernandes JD, Huang Y et al (2017) Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50CrossRef Ogurtsova K, da Rocha Fernandes JD, Huang Y et al (2017) Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50CrossRef
4.
go back to reference Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564CrossRef Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564CrossRef
5.
go back to reference Wu L, Fernandez-Loiaza P, Sauma J et al (2013) Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4:290–294CrossRef Wu L, Fernandez-Loiaza P, Sauma J et al (2013) Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4:290–294CrossRef
6.
go back to reference Olayiwola JN, Sobieraj DM, Kulowski K et al (2011) Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center. J Health Care Poor Underserved 3:804–816CrossRef Olayiwola JN, Sobieraj DM, Kulowski K et al (2011) Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center. J Health Care Poor Underserved 3:804–816CrossRef
7.
go back to reference Lin DY, Blumenkranz MS, Brothers R et al (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213CrossRef Lin DY, Blumenkranz MS, Brothers R et al (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213CrossRef
8.
go back to reference Wilkinson CP, Ferris FL, Klein RE et al (2003) Global Diabetic Retinopathy Study Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 9:1677–1682CrossRef Wilkinson CP, Ferris FL, Klein RE et al (2003) Global Diabetic Retinopathy Study Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 9:1677–1682CrossRef
9.
go back to reference Jones CD, Greenwood RH, Misra A et al (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596CrossRef Jones CD, Greenwood RH, Misra A et al (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596CrossRef
10.
go back to reference Agardh E, Poya Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in Type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319CrossRef Agardh E, Poya Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in Type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319CrossRef
11.
go back to reference Ku JJY, Landers J, Henderson T et al (2013) The reliability of single-field fundus photography in screening for diabetic retinopathy: The Central Australian Ocular Health Study. Med J Aust 198:93–96CrossRef Ku JJY, Landers J, Henderson T et al (2013) The reliability of single-field fundus photography in screening for diabetic retinopathy: The Central Australian Ocular Health Study. Med J Aust 198:93–96CrossRef
12.
go back to reference Pandit RJ, Taylor R (2002) Quality assurance in screening for sight-threatening diabetic retinopathy. Diabet Med 4:285–291CrossRef Pandit RJ, Taylor R (2002) Quality assurance in screening for sight-threatening diabetic retinopathy. Diabet Med 4:285–291CrossRef
13.
go back to reference Chin EK, Ventura BV, See KY, Seibles J, Park SS (2014) Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics. Telemed J E Health 20:102–108CrossRef Chin EK, Ventura BV, See KY, Seibles J, Park SS (2014) Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics. Telemed J E Health 20:102–108CrossRef
14.
go back to reference Scanlon PH (2017) Screening intervals for diabetic retinopathy and implications for care. Curr Diabet Rep 17:96CrossRef Scanlon PH (2017) Screening intervals for diabetic retinopathy and implications for care. Curr Diabet Rep 17:96CrossRef
15.
go back to reference Hudson SM, Contreras R, Kanter MH et al (2015) Centralized reading center improves quality in a real-world setting. Ophthalmic Surg Lasers Imaging Retina 46:624–629CrossRef Hudson SM, Contreras R, Kanter MH et al (2015) Centralized reading center improves quality in a real-world setting. Ophthalmic Surg Lasers Imaging Retina 46:624–629CrossRef
16.
go back to reference Chen G, Faris P, Hemmelgarn B, Walker RL, Quan H (2009) Measuring agreement of administrative data with chart data using prevalence unadjusted and adjusted kappa. BMC Med Res Methodol 9:5–12CrossRef Chen G, Faris P, Hemmelgarn B, Walker RL, Quan H (2009) Measuring agreement of administrative data with chart data using prevalence unadjusted and adjusted kappa. BMC Med Res Methodol 9:5–12CrossRef
18.
go back to reference Mendoza-Herrera K, Quezada AD, Pedroza-Tobias A et al (2017) A diabetic retinopathy screening tool for low-income adults in Mexico. Prev Chronic Dis 14:1–11CrossRef Mendoza-Herrera K, Quezada AD, Pedroza-Tobias A et al (2017) A diabetic retinopathy screening tool for low-income adults in Mexico. Prev Chronic Dis 14:1–11CrossRef
19.
go back to reference Williams GA, Scott IU, Haller JA et al (2004) Single field fundus photography for diabetic retinopathy screening. Ophthalmology 111:1055–1062CrossRef Williams GA, Scott IU, Haller JA et al (2004) Single field fundus photography for diabetic retinopathy screening. Ophthalmology 111:1055–1062CrossRef
20.
go back to reference Gulshan V, Peng L, Coram M et al (2016) Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316:2402–2410CrossRef Gulshan V, Peng L, Coram M et al (2016) Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316:2402–2410CrossRef
21.
go back to reference van der Heijden AA, Abramoff MD, Verbraak F et al (2018) Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol 96:63–68CrossRef van der Heijden AA, Abramoff MD, Verbraak F et al (2018) Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol 96:63–68CrossRef
22.
go back to reference Sayres R, Taly A, Rahimy E et al (2019) Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy. Ophthalmology 126:552–564CrossRef Sayres R, Taly A, Rahimy E et al (2019) Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy. Ophthalmology 126:552–564CrossRef
Metadata
Title
Diabetic retinopathy screening using a virtual reading center
Authors
Ronald B. Melles
Carol Conell
Scott W. Siegner
Dariusz Tarasewicz
Publication date
01-02-2020
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2020
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01392-9

Other articles of this Issue 2/2020

Acta Diabetologica 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.